This inventor holds 1 USPTO granted patent and 10 published patent applications. Top assignee: Dragonfly Therapeutics, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jinyan Du: Innovator in Cancer Therapeutics
Introduction
Jinyan Du is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of cancer therapeutics through his innovative work in protein binding technologies.
Latest Patents
Jinyan Du holds a patent for "Proteins binding NKG2D, CD16 and a tumor-associated antigen." This patent describes multi-specific binding proteins that interact with the NKG2D receptor, CD16, and various tumor-associated antigens. These antigens include c-MET, KIT, F3, IGF1R, Lewis Y, MUC13, MUC4, MCAM, LRRC32, sialyl-Tn, gpA33, GD3, GM2, EPHA3, TNFRSF10A, TNFSF11, CD74, and PMEL. The patent also outlines pharmaceutical compositions and therapeutic methods that are useful for treating cancer.
Career Highlights
Jinyan Du is currently associated with Dragonfly Therapeutics, Inc., where he continues to advance his research and development efforts in the field of oncology. His work is pivotal in creating innovative solutions for cancer treatment.
Collaborations
Some of his notable coworkers include Gregory P Chang and Ann F Cheung, who contribute to the collaborative efforts in their research initiatives.
Conclusion
Jinyan Du's innovative work in protein binding technologies represents a significant advancement in cancer therapeutics. His contributions are essential for the ongoing development of effective cancer treatments.